BOC Aviation Orders 50 Boeing 737 MAX Jets to Support Global Airlines
SEATTLE, March 30, 2025 /PRNewswire/ — Boeing and BOC Aviation have announced a new, firm order for 50 737-8 jets, expanding the lessor’s 737 MAX portfolio... Read more.
Li-S Energy collaborates with Kea Aerospace to power high altitude UAV flights
SYDNEY, March 30, 2025 /PRNewswire/ — Li-S Energy (ASX:LIS) (‘Li-S’ or ‘the Company’) has signed a collaboration agreement with Kea... Read more.
Akeso’s 2024 Results: Strengthening Global Competitiveness and Transforming the Treatment Landscape with Bispecific Antibodies
Key Highlights: Global first “immuno + anti-vascular” bispecific antibody approved: ivonescimab for EGFR-TKI resistant nsq-NSCLC. Phase III HARMONi study... Read more.
Medtronic Evolut™ TAVR system shows durable clinical outcomes and outstanding valve performance at five years in low-risk aortic stenosis patients
GALWAY, Ireland and CHICAGO, March 30, 2025 /PRNewswire/ — Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced late-breaking... Read more.
BFA’s 10th Religious Sub-forum Highlights Global Digitization Project of Buddhist Scriptures
QIONGHAI, China, March 30, 2025 /PRNewswire/ — The Sub-forum on Religious Harmony and Mutual Learning Among Civilizations took place at the BFA (BFA) Annual... Read more.
Brii Bio Unveils New Data from Its Ongoing Phase 2 ENSURE Study at APASL 2025, Showcasing BRII-179’s Unique Potential to Prime and Boost Higher HBsAg Loss Through Target Patient Identification
Preliminary data from Cohort 4 of the ENSURE study supports a novel enrichment strategy to utilize BRII-179 to identify patients who are immune responders and have... Read more.
Think you can do better than your team’s GM? Ultra GM gives you that chance.
MIAMI, April 1, 2025 /PRNewswire/ — Ultra GM, a new fantasy football platform, launches April 1, 2025. It offers an unmatched level of realism, allowing fans... Read more.
Oral semaglutide 14 mg demonstrated superior reduction in risk of cardiovascular events in late-breaking SOUL trial presented at the American College of Cardiology
SOUL study showed Rybelsus® (semaglutide) tablets 14 mg reduced the risk of major adverse cardiovascular events (MACE) by 14% (ARR 2% absolute risk reduction at... Read more.
How Medical Malpractice Cases Work in Florida: What Victims Need to Know
MIAMI, March 29, 2025 /PRNewswire/ — The Law Offices of Jason Turchin, a national personal injury firm, is educating Florida residents on how medical malpractice... Read more.
Eoptolink Launches 1.6T OSFP 2VR4 Transceivers Using 200G VCSELs
SAN FRANCISCO, March 29, 2025 /PRNewswire/ — Eoptolink Technology Inc., Ltd. (SZSE: 300502), a leading innovator and provider of advanced optical transceiver... Read more.